Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-03 @ 11:44 PM
Study NCT ID:
NCT05623267
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2022-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-12
First Submit QC Date:
None
Study First Post Date:
2022-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-04
Last Update Post Date:
2023-08-07
Last Update Post Date Type:
ACTUAL